文献速递腹部技术与安全MR

钆塞酸增强MRI上原发性肝癌的LI-RADS分类与预后

LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.
PubMed 文献 · Radiology · 2018-11-13

本回顾性研究纳入194例肝硬化且经手术证实的单发原发性肝癌患者,评估钆塞酸增强MRI的LI-RADS分类与术后预后关系,并检验2017版LI-RADS鉴别肝细胞癌与肝内胆管癌及混合性肝癌的效能。LI-RADS分类是总生存和无复发生存的独立因素,LR-M较LR-4或LR-5预后更差;LR-5诊断肝细胞癌敏感度69%、特异度87%,多数假阳性为混合性肝癌误分类。

要点

  • LI-RADS分类是原发性肝癌术后总生存(HR 4.2)和无复发生存(HR 2.6)的独立因素。
  • LR-M较LR-4或LR-5与更差的总生存和无复发生存相关。
  • LR-5诊断肝细胞癌敏感度69%(67/97)、特异度87%(84/97),假阳性85%(11/13)为混合性肝癌误分类。

核心结论

  • LI-RADS分类与原发性肝癌术后预后相关,且独立于病理诊断。
  • LI-RADS能正确分类大多数肝细胞癌和肝内胆管癌,但混合性肝癌与肝细胞癌的鉴别不可靠。

研究设计与样本

  • 回顾性研究,纳入2009年至2014年间194例肝硬化且经手术证实的单发原发性肝癌患者(混合性肝癌53例、肝内胆管癌44例、肝细胞癌97例),均行钆塞酸增强MRI。
  • 患者平均年龄57岁(范围30-83岁);男性155例平均年龄56岁(范围30-81岁),女性39例平均年龄58岁(范围38-83岁)。
  • 由两名独立阅片者分别对每个结节进行LI-RADS分类。
  • 采用Kaplan-Meier法、log-rank检验和Cox比例风险模型评估总生存、无复发生存及其相关因素。

诊断标准与关键数值

  • 多因素分析中,LI-RADS分类是总生存的独立因素(风险比4.2,P < .001)和无复发生存的独立因素(风险比2.6,P = .01)。
  • LR-M较LR-4或LR-5与更差的总生存和无复发生存相关:全部原发性肝癌P < .001(两者均P < .001),肝细胞癌P = .01和P < .001,混合性肝癌P = .01和P = .03。
  • LR-5诊断肝细胞癌的敏感度为69%(67/97),特异度为87%(84/97)。
  • LR-5诊断肝细胞癌的假阳性中85%(11/13)为混合性肝癌误分类所致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To (a) evaluate the postsurgical prognostic implication of the Liver Imaging Reporting and Data System (LI-RADS) categories of primary liver cancers and (b) determine the performance of LI-RADS version 2017 in differentiating hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (IHCC) and combined hepatocellular-cholangiocarcinoma (cHCC-CC) at gadoxetic acid-enhanced MRI. Materials and Methods In this retrospective study, 194 patients with cirrhosis and surgically proven single primary liver cancer (53 with cHCC-CC, 44 with IHCC, and 97 with HCC) were evaluated with gadoxetic acid-enhanced MRI between 2009 and 2014. The mean patient age was 57 years (age range, 30-83 years). There were 155 men with a mean age of 56 years (range, 30-81 years) and 39 women with a mean age of 58 years (range, 38-83 years). Two independent readers assigned an LI-RADS category for each nodule. Overall survival (OS), recurrence-free survival (RFS), and their associated factors were evaluated by using the Kaplan-Meier method, log-rank test, and Cox proportional hazard model. Results In the multivariable analysis, the LI-RADS category was an independent factor for OS (hazard ratio, 4.2; P < .001) and RFS (hazard ratio, 2.6; P = .01). The LR-M category showed more correlation with poorer OS and RFS than did the LR-4 or LR-5 category for all primary liver cancers (P < .001 for both), HCCs (P = .01 and P < .001, respectively), and cHCC-CCs (P = .01 and P = .03, respectively). The LR-5 category had a sensitivity of 69% (67 of 97) and a specificity of 87% (84 of 97) in the diagnosis of HCC; most false-positive diagnoses (85%, 11 of 13) were the result of misclassification of cHCC-CCs. Conclusion The Liver Imaging Reporting and Data System (LI-RADS) category was associated with postsurgical prognosis of primary liver cancers, independent of pathologic diagnosis. The LI-RADS enabled the correct classification of most hepatocellular carcinomas (HCCs) and intrahepatic cholangiocarcinomas, whereas differentiation of combined hepatocellular-cholangiocarcinoma from HCC was unreliable. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Bashir and Chernyak in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Choi SH, Lee SS, Park SH, et al. LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI. Radiology. 2018. PMID: 30422088. doi:10.1148/radiol.2018181290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。